Faculty

Institution

Unit

Venue

Lee Ellis

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Molecular And Cellular Oncology

NoneLee Ellis is currently serving as a Molecular And Cellular Oncology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Lee Ellis

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

oncology cancer research tumor biology cancer biology cell biology vascular biology cancer cells colorectal cancer pharmacology medicinal research oncogenes pathology radiation oncology cancer treatment angiogenesis cancer care cancer growth metastasis surgical oncology molecular cancer gastrointestinal oncology therapeutic targets clinical research liver cancer cancer discovery cellular therapy tumor microenvironment carcinogenesis cancer management pancreatic cancer gastrointestinal surgery tumor targeting anti-cancer agents molecular gastroenterology neovascularization cell regulation hepatocellular carcinoma pharmacotherapy therapeutic efficacy cancer genetics thoracic oncology cancer imaging cancer genomics tumor heterogeneity medical mycology leukemia novel therapies signaling pathways angiology hepatobiliary tumors radiofrequency ablation antiangiogenic therapy tumor growth disease progression human colon cancer metastatic colorectal cancer endothelial cells receptor tyrosine kinases tumor suppressors cytokines general surgery cohort studies biliary cancer clinical medicine viral oncology colorectal surgery phase ii trial colorectal liver metastases tumor angiogenesis advanced rectal cancer endothelial cell apoptosis murine model human pancreatic cancer pathologic response tumor vasculature overall survival

Notable Scholarly Works

Notable Federal Grants

Collaborators

Supplementary Figure 5 From Vincristine Enhances the Efficacy of Mek Inhibitors in Preclinical Models of Kras-Mutant Colorectal Cancer. (2025)

tumor biologycolorectal canceranti-cancer agentsmek inhibitorscancer researchoncologymolecular cancercancer biologysupplementary figure 5cell biologycancer cellskras-mutant colorectal canceroncogenespharmacologytherapeutic targetscancer discovery

Abstract Lb121: Endothelial Cells Mediated Paracrine Signaling Alters Immune Cell Modulators on Colorectal Cancer Cells. Cancer Research (2024)

tumor biologycancer immunotherapycolorectal cancermolecular cancercell biologycell signalingcancer cellsendothelial cellscancer immunosurveillanceimmunologycolorectal cancer cellsabstract lb121tumor microenvironment

Enhancing Efficacy of the Mek Inhibitor Trametinib With Paclitaxel in Kras -Mutated Colorectal Cancer. bioRxiv (Cold Spring Harbor Laboratory) (2024)

Susmita GhoshFan FanReid PowellYong ParkClifford StephanE. Scott KopetzLee M. EllisRajat Bhattacharya

colorectal cancertherapeutic efficacyanti-cancer agentskras-mutated colorectal cancermek inhibitor trametinibcancer researchoncologyoncogenespharmacologycancer treatmentmedicinal research

35P Enhancing Efficacy of the Mek Inhibitor Trametinib in Kras-Mutated Colorectal Cancer Cells. ESMO Open (2023)

tumor biologycolorectal cancermek inhibitor trametiniboncologymolecular cancercancer biologycell biologycancer cellsoncogenespharmacology

Abstract 4994: Crizotinib Enhances the Efficacy of Bx-795 Identified by High-Throughput Screening of Pan-Active Drugs in Colorectal Cancer Cells. Cancer Research (2023)

Susmita GhoshFan FanJason RoszikReid PowellYong ParkClifford StephanLee M. EllisRajat Bhattacharya

cancer biologyhigh-throughput screeningpharmacologytherapeutic targetscolorectal canceroncologycancer researchcancer carecancer treatmentdrug discoveryanti-cancer agentsradiation oncologytumor targetingmedicinal researchpharmacological researchoncogenespan-active drugscolorectal cancer cellsenzyme inhibitionclinical researchhealth sciences

Abstract B171: Bx-795 Enhances the Efficacy of Crizotinib in Colorectal Cancer Cells by Altering the Activity of Aurora Kinases. Molecular Cancer Therapeutics (2023)

anti-cancer agentsabstract b171cancer researchcell regulationcancer growthcancer biologycell biologycell signalingcancer cellsoncogenesaurora kinasespharmacologytherapeutic targetscolorectal cancer cellscancer discovery

Combining Mek and Src Inhibitors for Treatment of Colorectal Cancer Demonstrate Increased Efficacy in Vitro but Not in Vivo. PLoS ONE (2023)

tumor biologycolorectal canceranti-cancer agentscolorectal cancer demonstrateoncologymolecular cancersrc inhibitorscell biologycancer cellsoncogenespharmacologycancer treatmenttherapeutic targets

Data From Atp Citrate Lyase Mediates Resistance of Colorectal Cancer Cells to Sn38. (2023)

Yunfei ZhouLakshmi Reddy BolluFederico TozziXiangcang YeRajat BhattacharyaGuang GaoElizabeth DupreLing XiaJia LuFan FanSeth BellisterLee M. EllisZhang Weihua

hepatologytumor biologygeneticscolorectal canceroncologycancer biologycell biologyatp citrate lyasecolorectal cancer cellshealth sciences

Data From Endothelial Cells Promote Colorectal Cancer Cell Survival by Activating the Her3-Akt Pathway in a Paracrine Fashion. (2023)

Rui WangRajat BhattacharyaXiangcang YeFan FanDelphine R. BoulbesLee M. Ellis

hepatologytumor biologycolorectal cancermitochondrial functionparacrine fashioncancer researchoncologyhematological malignanciescancer biologytissue oxygenationdermatologycell biologycell signalingendothelial cellsdata sciencecancer carevascular biologymedicinal research

Data From Intracrine Vegf Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells. (2023)

tumor biologycolorectal cancerprosurvival pathwayscancer researchoncologycancer growthcancer biologyintracrine vegf signalingcell biologycancer cellsextracellular matrixmatrix biologypathology

1
2
3
4
5
43
10 / page

Lee Ellis

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Molecular And Cellular Oncology

NoneLee Ellis is currently serving as a Molecular And Cellular Oncology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Lee Ellis

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Supplementary Figure 5 From Vincristine Enhances the Efficacy of Mek Inhibitors in Preclinical Models of Kras-Mutant Colorectal Cancer. (2025)

Abstract Lb121: Endothelial Cells Mediated Paracrine Signaling Alters Immune Cell Modulators on Colorectal Cancer Cells. Cancer Research (2024)

Enhancing Efficacy of the Mek Inhibitor Trametinib With Paclitaxel in Kras -Mutated Colorectal Cancer. bioRxiv (Cold Spring Harbor Laboratory) (2024)

Susmita GhoshFan FanReid PowellYong ParkClifford StephanE. Scott KopetzLee M. EllisRajat Bhattacharya

colorectal cancertherapeutic efficacyanti-cancer agentskras-mutated colorectal cancermek inhibitor trametinibcancer researchoncologyoncogenespharmacologycancer treatmentmedicinal research

35P Enhancing Efficacy of the Mek Inhibitor Trametinib in Kras-Mutated Colorectal Cancer Cells. ESMO Open (2023)

tumor biologycolorectal cancermek inhibitor trametiniboncologymolecular cancercancer biologycell biologycancer cellsoncogenespharmacology

Abstract 4994: Crizotinib Enhances the Efficacy of Bx-795 Identified by High-Throughput Screening of Pan-Active Drugs in Colorectal Cancer Cells. Cancer Research (2023)

Susmita GhoshFan FanJason RoszikReid PowellYong ParkClifford StephanLee M. EllisRajat Bhattacharya

Abstract B171: Bx-795 Enhances the Efficacy of Crizotinib in Colorectal Cancer Cells by Altering the Activity of Aurora Kinases. Molecular Cancer Therapeutics (2023)

Combining Mek and Src Inhibitors for Treatment of Colorectal Cancer Demonstrate Increased Efficacy in Vitro but Not in Vivo. PLoS ONE (2023)

tumor biologycolorectal canceranti-cancer agentscolorectal cancer demonstrateoncologymolecular cancersrc inhibitorscell biologycancer cellsoncogenespharmacologycancer treatmenttherapeutic targets

Data From Atp Citrate Lyase Mediates Resistance of Colorectal Cancer Cells to Sn38. (2023)

Yunfei ZhouLakshmi Reddy BolluFederico TozziXiangcang YeRajat BhattacharyaGuang GaoElizabeth DupreLing XiaJia LuFan FanSeth BellisterLee M. EllisZhang Weihua

hepatologytumor biologygeneticscolorectal canceroncologycancer biologycell biologyatp citrate lyasecolorectal cancer cellshealth sciences

Data From Endothelial Cells Promote Colorectal Cancer Cell Survival by Activating the Her3-Akt Pathway in a Paracrine Fashion. (2023)

Rui WangRajat BhattacharyaXiangcang YeFan FanDelphine R. BoulbesLee M. Ellis

Data From Intracrine Vegf Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells. (2023)

tumor biologycolorectal cancerprosurvival pathwayscancer researchoncologycancer growthcancer biologyintracrine vegf signalingcell biologycancer cellsextracellular matrixmatrix biologypathology

1
2
3
4
5
43
10 / page